Y-Intercept (HK)’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-13,202
| Closed | -$1.46M | – | 1886 |
|
|
2025
Q1 | $1.46M | Buy |
+13,202
| New | +$1.46M | 0.1% | 268 |
|
|
2024
Q4 | – | Sell |
-31,781
| Closed | -$3.66M | – | 1498 |
|
|
2024
Q3 | $3.66M | Buy |
+31,781
| New | +$3.66M | 0.22% | 82 |
|
|
2024
Q2 | – | Sell |
-3,891
| Closed | -$537K | – | 1735 |
|
|
2024
Q1 | $537K | Buy |
+3,891
| New | +$537K | 0.04% | 676 |
|
|
2023
Q3 | – | Sell |
-3,937
| Closed | -$371K | – | 1409 |
|
|
2023
Q2 | $371K | Sell |
3,937
-2,279
| -37% | -$215K | 0.04% | 691 |
|
|
2023
Q1 | $629K | Buy |
6,216
+96
| +2% | +$9.72K | 0.07% | 416 |
|
|
2022
Q4 | $731K | Buy |
6,120
+2,475
| +68% | +$296K | 0.11% | 299 |
|
|
2022
Q3 | $387K | Buy |
+3,645
| New | +$387K | 0.04% | 626 |
|
|
2021
Q4 | – | Sell |
-2,738
| Closed | -$263K | – | 779 |
|
|
2021
Q3 | $263K | Buy |
+2,738
| New | +$263K | 0.05% | 505 |
|